Open AccessPD32-08 SYNERGISTIC ANTICANCER EFFECT OF COMBINATION TREATMENT WITH MEK INHIBITOR AND PI3K /MTOR DUAL INHIBITOR IN CASTRATION-RESISTANT PROSTATE CANCER IN VIVO AND EX VIVO
Author(s) -
SeYoung Choi,
Jaeyoon Jung,
Jae Hyeon Han,
Jung Hyun Shin,
Jeong-Woen Moon,
Sang Hoon Song,
Dalsan You,
Jung Jin Hwang,
ChoungSoo Kim
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.684
Subject(s) - medicine , pi3k/akt/mtor pathway , prostate cancer , pten , ex vivo , mek inhibitor , cancer , protein kinase b , cancer research , in vivo , pharmacology , mapk/erk pathway , apoptosis , kinase , chemistry , biology , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom